In the last 12 months, the renewables sector in India witnessed mergers and acquisitions activity to the tune of $3 billion, with both strategic and financial investors being active, according to Rothschild.
The firm, which currently has 18 staff in the country, is looking to hire from analyst to vice president levels across sectors such as health care and technology, according to Aalok Shah, managing director for India.
On October 25, 2019, the board of Jubilant Life Sciences announced a restructuring of the company into two separate entities -- one handling pharmaceuticals operations and the other its life science ingredient business.
A beginning of a multi-year bull market from the panic lows of March can be ruled out. Traders should remain alert without developing FOMO as fall can be a minimum of 10 percent as happened in the past.
SunEdison's 8 projects require an equity infusion of Rs 2,010 crore. It is learnt that Rothschild has been appointed as SunEdison's advisor, learns CNBC-TV18.
AstraZeneca, which has marketed roflumilast in the United States under the name Daliresp since the first quarter of 2015, said it would pay USD 575 million to the Japanese company.
As per the industry data, more than 30 companies have lined up plans to raise funds totalling over Rs 20,000 crore through public offers.